• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗疟药奎宁嗪抑制癌症干细胞的潜能:旧酒换新瓶。

Anti-Cancer Stem Cells Potentiality of an Anti-Malarial Agent Quinacrine: An Old Wine in a New Bottle.

机构信息

Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Campus-11, Patia, Bhubaneswar, Odisha 751024, India.

出版信息

Anticancer Agents Med Chem. 2021;21(4):416-427. doi: 10.2174/1871520620666200721123046.

DOI:10.2174/1871520620666200721123046
PMID:32698746
Abstract

Quinacrine (QC) is a tricyclic compound and a derivative of 9-aminoacridine. It has been widely used to treat malaria and other parasitic diseases since the last century. Interestingly, studies have revealed that it also displays anti-cancer activities. Here, we have discussed the anti-cancer mechanism of QC along with its potentiality to specifically target cancer stem cells. The anti-cancer action of this drug includes DNA intercalation, inhibition of DNA repair mechanism, prevention of cellular growth, cell cycle arrest, inhibition of DNA and RNA polymerase activity, induction of autophagy, promotion of apoptosis, deregulation of cell signaling in cancer cells and cancer stem cells, inhibition of metastasis and angiogenesis. In addition, we have also emphasized on the synergistic effect of this drug with other potent chemotherapeutic agents and mentioned its different applications in anti-cancer therapy.

摘要

盐酸奎宁(QC)是一种三环化合物,也是 9-氨基吖啶的衍生物。自上个世纪以来,它已被广泛用于治疗疟疾和其他寄生虫病。有趣的是,研究表明它还具有抗癌活性。在这里,我们讨论了 QC 的抗癌机制及其特异性靶向癌症干细胞的潜力。这种药物的抗癌作用包括 DNA 插入、抑制 DNA 修复机制、阻止细胞生长、细胞周期停滞、抑制 DNA 和 RNA 聚合酶活性、诱导自噬、促进细胞凋亡、调节癌细胞和癌症干细胞中的细胞信号转导、抑制转移和血管生成。此外,我们还强调了该药物与其他有效化疗药物的协同作用,并提到了它在癌症治疗中的不同应用。

相似文献

1
Anti-Cancer Stem Cells Potentiality of an Anti-Malarial Agent Quinacrine: An Old Wine in a New Bottle.抗疟药奎宁嗪抑制癌症干细胞的潜能:旧酒换新瓶。
Anticancer Agents Med Chem. 2021;21(4):416-427. doi: 10.2174/1871520620666200721123046.
2
Novel applications for an established antimalarial drug: tumoricidal activity of quinacrine.新型抗疟药物的新应用:盐酸奎宁的杀肿瘤活性。
Future Oncol. 2018 Jun;14(15):1511-1520. doi: 10.2217/fon-2017-0728. Epub 2018 Jan 30.
3
Enhancement of Cytotoxicity and Inhibition of Angiogenesis in Oral Cancer Stem Cells by a Hybrid Nanoparticle of Bioactive Quinacrine and Silver: Implication of Base Excision Repair Cascade.生物活性喹吖因与银的杂化纳米颗粒增强口腔癌干细胞的细胞毒性并抑制血管生成:碱基切除修复级联反应的影响
Mol Pharm. 2015 Nov 2;12(11):4011-25. doi: 10.1021/acs.molpharmaceut.5b00461. Epub 2015 Oct 16.
4
Quinacrine upregulates p21/p27 independent of p53 through autophagy-mediated downregulation of p62-Skp2 axis in ovarian cancer.金雀异黄素通过自噬介导的 p62-Skp2 轴下调上调卵巢癌细胞中的 p21/p27,而不依赖于 p53。
Sci Rep. 2018 Feb 6;8(1):2487. doi: 10.1038/s41598-018-20531-w.
5
Metallic gold and bioactive quinacrine hybrid nanoparticles inhibit oral cancer stem cell and angiogenesis by deregulating inflammatory cytokines in p53 dependent manner.金属金和生物活性吖啶酮杂交纳米粒子通过调节 p53 依赖性炎症细胞因子抑制口腔癌干细胞和血管生成。
Nanomedicine. 2018 Apr;14(3):883-896. doi: 10.1016/j.nano.2018.01.007. Epub 2018 Jan 31.
6
Nanoformulated quinacrine regulates NECTIN-4 domain specific functions in cervical cancer stem cells.纳米制剂奎纳克林调节宫颈癌干细胞中 NECTIN-4 结构域的特定功能。
Eur J Pharmacol. 2020 Sep 15;883:173308. doi: 10.1016/j.ejphar.2020.173308. Epub 2020 Jun 27.
7
Design and synthesis of novel quinacrine-[1,3]-thiazinan-4-one hybrids for their anti-breast cancer activity.新型盐酸奎宁-[1,3]-噻嗪烷-4-酮杂合体的设计与合成及其抗乳腺癌活性。
Eur J Med Chem. 2018 Jan 1;143:1028-1038. doi: 10.1016/j.ejmech.2017.11.097.
8
Anti-malaria drug blocks proteotoxic stress response: anti-cancer implications.抗疟药物阻断蛋白毒性应激反应:抗癌意义。
Cell Cycle. 2009 Dec;8(23):3960-70. doi: 10.4161/cc.8.23.10179. Epub 2009 Dec 25.
9
Chk1 inhibitor synergizes quinacrine mediated apoptosis in breast cancer cells by compromising the base excision repair cascade.Chk1抑制剂通过破坏碱基切除修复级联反应,增强奎纳克林介导的乳腺癌细胞凋亡。
Biochem Pharmacol. 2016 Apr 1;105:23-33. doi: 10.1016/j.bcp.2016.01.017. Epub 2016 Feb 2.
10
Repurposing Quinacrine for Treatment of Malignant Mesothelioma: In-Vitro Therapeutic and Mechanistic Evaluation.将奎纳克林重新用于治疗恶性间皮瘤:体外治疗及机制评估
Int J Mol Sci. 2020 Aug 31;21(17):6306. doi: 10.3390/ijms21176306.

引用本文的文献

1
Cytotoxic, Genotoxic, Apoptotic, and Reactive Oxygen Generating Properties of Bioactive Quinoline Derivatives as Novel Anti Breast Cancer Agents.生物活性喹啉衍生物作为新型抗乳腺癌药物的细胞毒性、遗传毒性、凋亡诱导及活性氧生成特性
Cell Biochem Biophys. 2025 Jun 10. doi: 10.1007/s12013-025-01793-4.
2
Monocyte/macrophage-mediated venous thrombus resolution.单核细胞/巨噬细胞介导的静脉血栓溶解。
Front Immunol. 2024 Jul 19;15:1429523. doi: 10.3389/fimmu.2024.1429523. eCollection 2024.
3
AI identifies potent inducers of breast cancer stem cell differentiation based on adversarial learning from gene expression data.
人工智能基于基因表达数据的对抗学习识别乳腺癌干细胞分化的有效诱导剂。
Brief Bioinform. 2024 Mar 27;25(3). doi: 10.1093/bib/bbae207.
4
A novel enemy of cancer: recent investigations into protozoan anti-tumor properties.癌症的新型克星:原生动物抗肿瘤特性的最新研究
Front Cell Infect Microbiol. 2024 Jan 11;13:1325144. doi: 10.3389/fcimb.2023.1325144. eCollection 2023.
5
Quinacrine inhibits cMET-mediated metastasis and angiogenesis in breast cancer stem cells.喹吖因可抑制乳腺癌干细胞中cMET介导的转移和血管生成。
J Cell Commun Signal. 2023 Dec;17(4):1371-1388. doi: 10.1007/s12079-023-00756-9. Epub 2023 May 10.
6
Quinacrine and Curcumin in combination decreased the breast cancer angiogenesis by modulating ABCG2 via VEGF A.奎纳克林和姜黄素联合使用通过VEGF A调节ABCG2来降低乳腺癌血管生成。
J Cell Commun Signal. 2023 Sep;17(3):609-626. doi: 10.1007/s12079-022-00692-0. Epub 2022 Nov 3.
7
A 9-aminoacridine derivative induces growth inhibition of Ehrlich ascites carcinoma cells and antinociceptive effect in mice.一种9-氨基吖啶衍生物可诱导艾氏腹水癌细胞生长抑制并在小鼠中产生抗伤害感受作用。
Front Pharmacol. 2022 Oct 17;13:963736. doi: 10.3389/fphar.2022.963736. eCollection 2022.
8
Targeting Ribosome Biogenesis in Cancer: Lessons Learned and Way Forward.靶向癌症中的核糖体生物合成:经验教训与未来方向
Cancers (Basel). 2022 Apr 24;14(9):2126. doi: 10.3390/cancers14092126.